179 related articles for article (PubMed ID: 7527822)
1. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
[TBL] [Abstract][Full Text] [Related]
2. In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras.
MacDonald GC; Kakkanaiah VN; Sobel ES; Cohen PL; Eisenberg RA
J Immunol; 1995 Jan; 154(1):444-9. PubMed ID: 7527820
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
Giese T; Davidson WF
J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
[TBL] [Abstract][Full Text] [Related]
4. Differential control of autoantibodies and lymphoproliferation by Fas ligand expression on CD4+ and CD8+ T cells in vivo.
Maldonado MA; MacDonald GC; Kakkanaiah VN; Fecho K; Dransfield M; Sekiguchi D; Cohen PL; Eisenberg RA
J Immunol; 1999 Sep; 163(6):3138-42. PubMed ID: 10477580
[TBL] [Abstract][Full Text] [Related]
5. Defective T cells from gld mice play a pivotal role in development of Thy-1.2+B220+ cells and autoimmunity.
Yasutomo K; Maeda K; Nagata S; Nagasawa H; Okada K; Good RA; Kuroda Y; Himeno K
J Immunol; 1994 Dec; 153(12):5855-64. PubMed ID: 7527451
[TBL] [Abstract][Full Text] [Related]
6. lpr T cells are necessary for autoantibody production in lpr mice.
Sobel ES; Cohen PL; Eisenberg RA
J Immunol; 1993 May; 150(9):4160-7. PubMed ID: 8473754
[TBL] [Abstract][Full Text] [Related]
7. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
[TBL] [Abstract][Full Text] [Related]
8. Cellular interactions in the lpr and gld models of systemic autoimmunity.
Sobel ES
Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
[TBL] [Abstract][Full Text] [Related]
10. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene.
Sobel ES; Kakkanaiah VN; Cohen PL; Eisenberg RA
Int Immunol; 1993 Oct; 5(10):1275-8. PubMed ID: 7505611
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
Weintraub JP; Eisenberg RA; Cohen PL
J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
[TBL] [Abstract][Full Text] [Related]
13. gld/gld mice are unable to express a functional ligand for Fas.
Ramsdell F; Seaman MS; Miller RE; Tough TW; Alderson MR; Lynch DH
Eur J Immunol; 1994 Apr; 24(4):928-33. PubMed ID: 7512035
[TBL] [Abstract][Full Text] [Related]
14. Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.
Sobel ES; Kakkanaiah VN; Schiffenbauer J; Reap EA; Cohen PL; Eisenberg RA
J Immunol; 1998 Feb; 160(3):1497-503. PubMed ID: 9570572
[TBL] [Abstract][Full Text] [Related]
15. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
[TBL] [Abstract][Full Text] [Related]
16. The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice.
Eisenberg RA; Sobel ES; Reap EA; Halpern MD; Cohen PL
Semin Immunol; 1994 Feb; 6(1):49-54. PubMed ID: 8167307
[TBL] [Abstract][Full Text] [Related]
17. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
Glaser RM; Marshak-Rothstein A
Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698
[TBL] [Abstract][Full Text] [Related]
18. The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo.
Fossati L; Sobel ES; Iwamoto M; Cohen PL; Eisenberg RA; Izui S
Eur J Immunol; 1995 Dec; 25(12):3412-7. PubMed ID: 8566031
[TBL] [Abstract][Full Text] [Related]
19. Fas system-mediated apoptosis suppresses lymphopoiesis.
Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
[TBL] [Abstract][Full Text] [Related]
20. Development of grafted gld cells in athymic and euthymic recipients.
Rosenblatt N; Hartmann KU; Loor F
Immunology; 1995 Apr; 84(4):562-70. PubMed ID: 7790030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
